Normal Tissue Complication Probability after hypofractionation increased due to the high dose per fraction or the high total Biological Equivalent Dose?

Comment

Gerben R Borst et al. Radiother Oncol. 2010 Mar.

. 2010 Mar;94(3):388.

doi: 10.1016/j.radonc.2010.01.023. Epub 2010 Feb 25.

No abstract available

Comment on

Acute skin toxicity following stereotactic body radiation therapy for stage I non-small-cell lung cancer: who's at risk?
Hoppe BS, Laser B, Kowalski AV, Fontenla SC, Pena-Greenberg E, Yorke ED, Lovelock DM, Hunt MA, Rosenzweig KE. Hoppe BS, et al. Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1283-6. doi: 10.1016/j.ijrobp.2008.08.036. Int J Radiat Oncol Biol Phys. 2008. PMID: 19028267
Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites.
Forquer JA, Fakiris AJ, Timmerman RD, Lo SS, Perkins SM, McGarry RC, Johnstone PA. Forquer JA, et al. Radiother Oncol. 2009 Dec;93(3):408-13. doi: 10.1016/j.radonc.2009.04.018. Epub 2009 May 18. Radiother Oncol. 2009. PMID: 19454366